STAGE IIIC2 CERVICAL CANCER FIGO 2018
Clinical trials for STAGE IIIC2 CERVICAL CANCER FIGO 2018 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC2 CERVICAL CANCER FIGO 2018 trials appear
Sign up with your email to follow new studies for STAGE IIIC2 CERVICAL CANCER FIGO 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Vaccine boosts immune attack on cervical cancer in new trial
Disease control OngoingThis phase 2 trial tests whether adding an experimental vaccine called PDS0101 to standard chemoradiation is safe and helps control advanced cervical cancer. The vaccine is designed to train the immune system to recognize and attack HPV-infected cancer cells. About 22 adults with…
Matched conditions: STAGE IIIC2 CERVICAL CANCER FIGO 2018
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Blood test could spot cervical cancer return earlier
Knowledge-focused OngoingThis study looks at whether a blood test can find DNA from the HPV virus that causes cervical cancer. Researchers will collect blood samples from 18 people with cervical cancer before, during, and after treatment. The goal is to see if the test can predict how well treatment work…
Matched conditions: STAGE IIIC2 CERVICAL CANCER FIGO 2018
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 23, 2026 21:04 UTC